Advertisement

Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake

  • Chidambaram Natrajan Balasubramanian Harisankar
  • Bhagwant Rai MittalEmail author
  • Kanhaiya Lal Agrawal
  • Mohammed Labeeb Abrar
  • Anish Bhattacharya
Original Article

Abstract

Introduction

Fluoro-deoxy-glucose (FDG) can be used to visualize inflammation in atherosclerotic plaques in coronary arteries, if myocardial FDG uptake is adequately suppressed. Prolonged fasting for suppressing myocardial FDG uptake is inconsistent. We evaluated the feasibility to consistently suppress myocardial FDG uptake with a low carbohydrate high fat protein permitted (LCHFPP) diet.

Materials and methods

This was a prospective study. 50 patients were included in fasting group (>12 hours fasting) and 60 patients were included into LCHFPP diet. Fasting group had no special dietary preparation. Patients in LCHFPP diet group were asked to consume LCHFPP diet the night before and 4 hours prior to the study. Visual analysis of myocardial FDG uptake was done on maximum intensity projection image. Using CT images for localization, the ability to delineate possible FDG uptake in the left coronary artery was assessed in the corresponding PET image and the studies were classified as “interpretable” or “Not interpretable”.

Results

60 patients (mean age 47 years) from LCHFPP diet group and 50 patients (mean age 49.9 years) from fasting group were included. None of the patients were known diabetics. The mean blood glucose level was 96 mg/dL. Forty-eight patients had consumed LCHFPP diet as per protocol. Twelve had consumed LCHFPP diet only on the night before the study (non-compliant). The average duration of fasting in compliant patients was 5.9 ± 0.9 hours in the diet group and 14.6 hours in fasting group. In LCHFPP diet group, the myocardial FDG uptake was classified as complete suppression in 31; minimal uptake in 15; moderate inhomogenous uptake in 8 and homogenous intense uptake in 6 patients. Fifty-four of the 60 patients had interpretable study. When non-compliant patients were excluded, 84% of the patients had significant FDG uptake suppression and 94% of the studies were classified as interpretable. In the fasting group, complete myocardial suppression of FDG uptake was noticed in 16; minimal in 8; moderate inhomogenous in 15; and homogenous intense in 11 patients. 27 patients (54%) had interpretable study.

Conclusion

Consistent and significant myocardial FDG uptake suppression is possible in most patients using LCHFPP diet. The LCHFPP diet, if taken as per protocol, leads to consistent myocardial FDG uptake suppression to allow for adequate evaluation of the left coronary artery inflammation in nearly all the patients. LCHFPP diet is also significantly more efficacious than prolonged (>12 hours) fasting protocol in suppressing myocardial FDG uptake.

Key Words

PET/CT imaging FDG uptake suppression diet 

Notes

Acknowledgments

The authors acknowledge with thanks Mr. Banchha Nidhi Behera, Assistant Dietician in the department of dietetics, PGIMER, Chandigarh for helping in choosing the diet described in the paper.

References

  1. 1.
    Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992;326:242-50.PubMedCrossRefGoogle Scholar
  2. 2.
    Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988;12:56-62.PubMedCrossRefGoogle Scholar
  3. 3.
    Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988;78:1157-66.PubMedCrossRefGoogle Scholar
  4. 4.
    Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-75.PubMedCrossRefGoogle Scholar
  5. 5.
    Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.PubMedCrossRefGoogle Scholar
  6. 6.
    van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.PubMedGoogle Scholar
  7. 7.
    Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708-11.PubMedCrossRefGoogle Scholar
  8. 8.
    Abel ED. Glucose transport in the heart. Front Biosci 2004;9:201-15.PubMedCrossRefGoogle Scholar
  9. 9.
    Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol 2008;190:W151-6.PubMedCrossRefGoogle Scholar
  10. 10.
    Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S, et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med 2009;50:563-8.PubMedCrossRefGoogle Scholar
  11. 11.
    Davies JR, Rudd JH, Fryer TD, Graves MJ, Clark JC, Kirkpatrick PJ, et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 2005;36:2642-7.PubMedCrossRefGoogle Scholar
  12. 12.
    Okane K, Ibaraki M, Toyoshima H, Sugawara S, Takahashi K, Miura S, et al. 18F-FDG accumulation in atherosclerosis: use of CT and MR co-registration of thoracic and carotid arteries. Eur J Nucl Med Mol Imaging 2006;33:589-94.PubMedCrossRefGoogle Scholar
  13. 13.
    Israel O, Weiler-Sagie M, Rispler S, Bar-Shalom R, Frenkel A, Keidar Z, et al. PET/CT quantitation of the effect of patient-related factors on cardiac 18F-FDG uptake. J Nucl Med 2007;48:234-9.PubMedGoogle Scholar
  14. 14.
    de Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging 2005;32:98-101.PubMedCrossRefGoogle Scholar
  15. 15.
    Frayn KN. The glucose-fatty acid cycle: a physiological perspective. Biochem Soc Trans 2003;31:1115-9.PubMedCrossRefGoogle Scholar
  16. 16.
    Cheng VY, Slomka PJ, Ahlen M, Thomson LE, Waxman AD, Berman DS. Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: A randomized controlled trial. J Nucl Cardiol 2010;17:286-91.PubMedCrossRefGoogle Scholar
  17. 17.
    Dilsizian V. 18F-FDG uptake as a surrogate marker for antecedent ischemia. J Nucl Med 2008;49:1909-11.PubMedCrossRefGoogle Scholar
  18. 18.
    Dou KF, Yang MF, Yang YJ, Jain D, He ZX. Myocardial 18F-FDG uptake after exercise-induced myocardial ischemia in patients with coronary artery disease. J Nucl Med 2008;49:1986-91.PubMedCrossRefGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2011

Authors and Affiliations

  • Chidambaram Natrajan Balasubramanian Harisankar
    • 1
  • Bhagwant Rai Mittal
    • 1
    Email author
  • Kanhaiya Lal Agrawal
    • 1
  • Mohammed Labeeb Abrar
    • 1
  • Anish Bhattacharya
    • 1
  1. 1.Department of Nuclear Medicine & PETPostgraduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations